WT1 Peptide Vaccine is Unaffected by Airport Screening X-Irradiation, (Y.Higuchi), M.Kawakubo, M.Yuzawa, K.Sano, S.Shimodaira, Austin Journal of Vaccines & Immunotherapeutics, 3:1010-1010, 2016年09月
Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathwaymediated Killer Activity, (T.Koya), R.Yanagisawa, Y.Higuchi, K.Sano, S.Shimodaira, Scientific Reports, 3:1-4, 2017年02月
Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas LIgand Pathway-mediated Killer Activity, Terutsugu Koya,Ryu Yanagisawa,Yumiko Higuchi,Kenji Sano&Shigetaka Shimodaira, SCIENTIFIC REPORTS, 7:42145, 2017年02月
Significance of Wilms tumor 1 antigen as a canser vaccine for pancreatic cancer, Koido.S, Okamoto.M ,Kobayashi.M, Shimodaira.S, Sugiyama.H, Discovery Medicine, 130:41-49, 2017年08月
Clinical effect and immunological response in patients with advanced malignant glioma treated with WT1-pulsed dendritic cell-based immunotherapy: A report of two cases., Sakai K, Shimodaira S, Maejima S, Sano K, Higuchi Y, Koya T, Sugiyama H, Hongo K., Interdisciplinary Neurosurgery, 9:24-29, 2017年
Administration of platelet concentrates suspended in bicarbonated Ringer's solution in children who had platelet transfusion reactions, (Kobayashi J), Yanagisawa R, Ono T, Tatsuzawa Y, Tokutake Y, Kubota N, Hidaka E, Sakashita K, Kojima S, Shimodaira S, Nakamura T, VOX SANGUINIS, 113:128-135, 2018年02月
Comparison of administration of platelet concentrates suspended in M-sol or BRS-A for pediatric patients, (Shunsuke Kojima), Ryu Yanagisawa, Miyuki Tanaka, Yozo Nakazawa, Shigetaka Shimodaira, TRANSFUSION, 58:2952-2958, 2018年12月
Evaluation of Gelatin-Hybridized Chelate-Setting Calcium Phosphate Cements in Alveolar Bone Defects of Canine Mandible, Goichi Matsumoto, Yoshihiko Sugita, Katsutoshi Kubo, Waka Yoshida, Hatsuhiko Maeda, Mamoru Aizawa, Shigetaka Shimodaira, Yukihiko Kinoshita, Biomedical Journal of Scientific & Technical Research, 3:3420-3426, 2018年04月
Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors, (Hirabayashi K), Yanagisawa R, Saito S, Higuchi Y, Koya T, Sano K, Koido S, Okamoto M, Sugiyama H, Nakazawa Y, Shimodaira S, ANTICANCER RESEARCH, 38:2227-2234, 2018年04月
Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma, (Tomoya Kanai), Zensho Ito, Yusuke Oji, Machi Suka, Sumiyuki Nishida, Kazuki Takakura, Mikio Kajihara, Masayuki Saruta, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Shigetaka Shimodaira, Masato Okamoto, Haruo Sugiyama, Shigeo Koido, Oncology Letters, 16:2682-2692, 2018年08月
WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study, (Yanagisawa R), Koizumi T, Koya T, Sano K, Koido S, Nagai K, Kobayashi M, Okamoto M, Sugiyama H, Shimodaira S, ANTICANCER RESEARCH, 38:2217-2225, 2018年04月
Dendritic Cells Pre-Pulsed With Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination, Terutsugu Koya, Ippei Date, Haruhiko Kawaguchi, Asuka Watanabe, Takuya Sakamoto, Misa Togi, Tomohisa Kato Jr, Kenichi Yoshida, Shunsuke Kojima, Ryu Yanagisawa, Shigeo Koido, Haruo Sugiyama , Shigetaka Shimodaira, Pharmaceutics, 12: , 2020年03月
Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia, (Shoji Saito), Chiaki Taira, Kazuyuki Matsuda, Ryu Yanagisawa, Daisuke Morita, Tomonari Shigemura, Kentaro Yoshikawa, Miyuki Tanaka, Kazuo Sakashita, Saki Mukai, Shigetaka Shimodaira, Kenichi Koike, Yozo Nakazawa, Leukemia & Lymphoma, 61:967-970, 2020年04月
Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS‐A in adult patients, (Manjiro Yamanaka), Ryu Tanagisawa, Shunsuke Kojima, Hideyuki Nakazawa, Shigetaka Shimodaira, Transfusion, 59:3405-3412, 2019年12月
Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1, (Ito Z), Kan S, Bito T, Horiuchi S, Akasu T, Yoshida S, Kajihara M, Hokari A, Saruta M, Yoshida N, Kobayashi M, Ohkusa T, Shimodaira S, Okamoto M, Sugiyama H, Koido S, Oncology, 97:135-148, 2019年09月
In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination, Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr, Kobayashi T, Koizumi T, Koido S, Sugiyama H, Vaccines (Basel), 7:120, 2019年09月
